Toshiyuki Nomura
Fujisawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent.
Journal: Journal of medicinal chemistry
Published: January 03, 2020
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
Journal: EMBO molecular medicine
Published: May 18, 2018
The Anti-tumor Effect of Cabozantinib on Ovarian Clear Cell Carcinoma In Vitro and In Vivo.
Journal: Anticancer research
Published: June 23, 2017
LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B.
Journal: Cancer research
Published: December 22, 2016
A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells.
Journal: Molecular cancer therapeutics
Published: July 19, 2016
CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor.
Journal: Nature communications
Published: June 13, 2016
Biological characterization of TAK-901, an investigational, novel, multitargeted Aurora B kinase inhibitor.
Journal: Molecular cancer therapeutics
Published: January 30, 2013
Clinical evaluation of vertigo in menopausal women
Journal: Nihon Jibiinkoka Gakkai kaiho
Published: June 13, 2012
Non-specific exercise therapy for benign paroxysmal postural vertigo
Journal: Nihon Jibiinkoka Gakkai kaiho
Published: January 19, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026